Clinical trial
Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of…
NCT00116129 · Bennett, Robert, M.D., Other · Completed
Key facts
| NCT number | NCT00116129 |
|---|---|
| Title | Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in the Treatment of Primary Fibromyalgia |
| Lead sponsor | Bennett, Robert, M.D., Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Ibutamoren Mesylate (MK-0677) |
| Enrollment | 64 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jun 28, 2005 |
| Last update posted | Aug 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: